Table 2.
Baseline characteristics, risk factors, and stroke severity
|
sifap1 (n = 5023) |
GQH (n = 17007) |
|
|---|---|---|
| Sex (males) (n = 5023, sifap1) |
59% |
60.5% |
| Age (years); median and 25th-75th percentile |
46 (40-51) |
49 (44-53) |
| Previous (symptomatic) cerebrovascular event (n = 5022, sifap1) |
16.8% |
10.9%*** |
| Event entities |
|
|
| TIA |
22.3% |
31.1%***a |
| Brain infarction |
70.7% |
54.3% |
| Primary haemorrhage |
5.6% |
8.7% |
| Others† |
1.4% |
5.9% |
| Missing cases |
217 |
- |
| Vascular risk profile |
|
|
| Hypertension (n = 4994, sifap1) |
47% |
49%* |
| Diabetes (n = 4996, sifap1) |
10% |
13.3%*** |
| Current smoking (n = 5022, sifap1) |
41.4% |
38.5%*** |
| Stroke severity |
|
|
| NIH stroke scale (median; 25th-75th percentile) |
3 (1-6)║ |
3 (1-6)‡ |
| Modified rankin scale (median; 25th-75th percentile) | 2 (1-3)║ | 2 (1-3)§ |
†consider subarachnoid haemorrhage and cerebral sinus or vein thrombosis.
║assessed within the first 48 hours.
‡assessed on admission.
§assessed one day after admission.
*p < 0.05.
**p < 0.01.
***p < 0.001.
athe test statistic was calculated by using all entity categories.